Nurix Therapeutics (NRIX) Current Assets (2019 - 2025)
Historic Current Assets for Nurix Therapeutics (NRIX) over the last 7 years, with Q4 2025 value amounting to $606.8 million.
- Nurix Therapeutics' Current Assets fell 202.91% to $606.8 million in Q4 2025 from the same period last year, while for Nov 2025 it was $606.8 million, marking a year-over-year decrease of 202.91%. This contributed to the annual value of $606.8 million for FY2025, which is 202.91% down from last year.
- According to the latest figures from Q4 2025, Nurix Therapeutics' Current Assets is $606.8 million, which was down 202.91% from $440.6 million recorded in Q3 2025.
- Nurix Therapeutics' Current Assets' 5-year high stood at $619.4 million during Q4 2024, with a 5-year trough of $251.0 million in Q1 2024.
- Its 5-year average for Current Assets is $384.1 million, with a median of $336.7 million in 2022.
- In the last 5 years, Nurix Therapeutics' Current Assets tumbled by 2449.4% in 2023 and then soared by 12461.06% in 2025.
- Over the past 5 years, Nurix Therapeutics' Current Assets (Quarter) stood at $311.1 million in 2021, then rose by 2.36% to $318.4 million in 2022, then dropped by 7.21% to $295.5 million in 2023, then soared by 109.6% to $619.4 million in 2024, then decreased by 2.03% to $606.8 million in 2025.
- Its Current Assets stands at $606.8 million for Q4 2025, versus $440.6 million for Q3 2025 and $515.3 million for Q2 2025.